← Back

Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications

This program funds activities that develop personalised approaches to lower adverse drug reactions from taking three or more medicines, improving patient health outcomes. It supports research, guidelines, and education that help healthcare professionals use genetic and biomarker data to optimise medication use and reduce related hospital admissions.

Amount
€8M — €10M
Type
Program

Key facts

Key facts for Personalised approaches to reduce risks from Adverse Drug Reactions due to administration of multiple medications
Amount€8M — €10M — €38M shared across the programme
IssuerHorizon Europe
Who can applySee eligibility details
SectorsAI/ML · HealthTech
DeadlineCloses 17 Feb 2027

Unlock application details

See all eligibility criteria, required documents and the official application link. Free account, no card.

Update history

Source: ec.europa.eu ↗

Source checked 11 hours ago

  1. 10 days agoagentImported from the official source